510(k) · Cleared
ClearedJabra Enhance Plus
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
GN Hearing A/S · QDD Self-Fitting Air-Conduction Hearing Aid, Prescription
Cleared on Jan 19, 2022 as substantially equivalent to DEN180026 (Bose Corporation, 2018) after a 90-day review. Its family tree reaches back 1 generation to 2018. 1 later device descends from it.
- Decided
- Jan 19, 2022
- Review
- 90 days
- Class
- Class II
- Product code
- QDD
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to DEN180026 (2018). 1 later device descends from it, 1 citing it directly.
Most influential descendants
Showing 1 of 1 · See all- K254108Jabra Enhance Select Self-fit (Jabra Enhance Select 550)GN Hearing A/S · 2026 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | DEN180026 | Bose Hearing Aid | Bose Corporation | 2018 | — |
| 0 (this device) | K213424 | Jabra Enhance Plus | GN Hearing A/S | 2022 | — |
| +1 | K254108 | Jabra Enhance Select Self-fit (Jabra Enhance Select 550) | GN Hearing A/S | 2026 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QDD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new QDD device
- #1 K211008 Bose SoundControl Hearing Aidsscore 19.3 · 1 generation · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | DEN180026 | Bose Hearing AidSummary page 6…Classification Class II Panel Ear, Nose and Throat Devices Predicate Device Bose® Hearing Aid (DEN180026) Device Description The Jabra Enhance Plus is a wireless, self-fitting air-conduction hearing aid system. It incorporates microp… | 2018 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K254108 | Jabra Enhance Select Self-fit (Jabra Enhance Select 550) | 2026 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All QDD devicesQDD Self-Fitting Air-Conduction Hearing Aid, Prescription: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.
FDA decisions per year · QDD
1in 2023
2026 to Oct 25, outlined.
Median 510(k) review, days · QDD
162in 2022
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · QDD
No recall names QDD since 2007.
Adverse event reports per year · QDD
2in 2024
MAUDE reports naming product code QDD, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 1 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 1 | — | 0 | 0 |
| 2022 | 4 | 162 | 0 | 1 |
| 2023 | 1 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 2 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Jabra Enhance Plus self-fitting hearing aid is intended to amplify sound for individuals 18 years of age or older with perceived mild to moderate hearing impairment. It is adjusted by the user to meet the user's hearing needs. No pre-programming or hearing test is necessary. The device is intended for direct-to-consumer sale and use without the assistance of a hearing care professional.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K213424 · printed Nov 6, 2026
Cite this page
510(k) Report. “K213424: Jabra Enhance Plus.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K213424
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026